Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
5.21
-0.45 (-7.88%)
At close: Jul 3, 2025, 4:00 PM
5.11
-0.09 (-1.83%)
Pre-market: Jul 7, 2025, 4:34 AM EDT

Psyence Biomedical Ratios and Metrics

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022
Period Ending
Jul '25 Mar '25 Mar '24 Mar '23 Mar '22
2831597327
Market Cap Growth
-82.21%-82.21%-84.31%-70.25%-
Enterprise Value
2221596-
Last Close Price
5.214.78681.446338.685983.49
PE Ratio
0.992.69---
PB Ratio
0.060.40-1.39-485.51192.37
P/TBV Ratio
4.140.40--192.37
Debt / Equity Ratio
---0.95--
Quick Ratio
10.5510.550.060.8313.62
Current Ratio
11.0411.040.090.8913.90
Return on Equity (ROE)
----468.63%-
Return on Assets (ROA)
-54.20%-54.20%-126.35%-123.25%-
Return on Capital (ROIC)
-73.88%-73.88%--295.49%-
Earnings Yield
3.64%37.25%-335.14%-3.29%-0.57%
FCF Yield
-13.46%-137.84%-19.33%-1.64%-0.43%
Buyback Yield / Dilution
-1670.55%-1670.55%---
Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q